RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer

J Natl Cancer Inst. 2022 Apr 11;114(4):635-636. doi: 10.1093/jnci/djab216.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bone Neoplasms* / drug therapy
  • Bone Neoplasms* / secondary
  • Castration
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms* / surgery
  • Prostatic Neoplasms, Castration-Resistant* / drug therapy
  • Prostatic Neoplasms, Castration-Resistant* / pathology